Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Regeneron Pharmaceuticals Inc. June 14, 202491.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +7,830 | $376.69 | $2,949,483 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +7,439 | $380.95 | $2,833,887 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1,224 | $960.57 | $1,175,738 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −540 | $961.85 | $519,399 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −2,522 | $962.61 | $2,427,702 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4,338 | $963.47 | $4,179,533 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −2,670 | $964.57 | $2,575,402 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −7,073 | $965.38 | $6,828,133 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1,522 | $966.27 | $1,470,663 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1,040 | $967.07 | $1,005,753 |
| Nov 2, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −200 | $970.18 | $194,036 |
| Jan 2, 2026 | Regeneron Pharmaceuticals Inc. | Grant or award | +155 | — | — |
| Dec 30, 2025 | Regeneron Pharmaceuticals Inc. | Option exercise | +9,212 | $520.01 | $4,790,332 |
| Dec 30, 2025 | Regeneron Pharmaceuticals Inc. | Shares withheld for tax | −6,188 | $774.03 | $4,789,698 |
| Jan 2, 2025 | Regeneron Pharmaceuticals Inc. | Grant or award | +166 | — | — |
Questions about George L. Sing
What boards is George L. Sing on?
George L. Sing sits on the board of Regeneron Pharmaceuticals Inc.
How long has George L. Sing served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.